Abeona Therapeutics Inc (ABEO) Stock Price Today
Key Stats
- $286.49MMarket Cap
- 1,475,220Volume
- HealthSector
- $7.4652W High
- $4.1752W Low
- 24 DaysTypical Hold Time
- $159.54MEnterprise Value
- -Div Yield
- 0% Sell | 100% BuyTrading Activity
Track Abeona Therapeutics Inc (ABEO) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Abeona Therapeutics Inc has traded between a low of $4.17 and a high of $7.46, highlighting its annual price range. Buy and sell Abeona Therapeutics Inc shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Abeona Therapeutics Inc
Abeona Therapeutics develops gene and cell therapies for rare diseases. Its lead product, ZEVASKYN, is an FDA-approved therapy for recessive dystrophic epidermolysis bullosa (RDEB), a severe and life-threatening genetic skin disorder.
Most Recent News
Joby Aviation director sells shares amid eVTOL progress and financial challenges
A director at Joby Aviation sold 62,500 shares worth $380,625 while keeping a large stake. Joby is advancing its electric vertical take-off and landing (eVTOL) aircraft, aiming for passenger flights in Dubai by late 2026 pending FAA approval. Despite...

Shares of Nexalin, Integra LifeSciences, Western Digital, and Seagate plunge on operational and competition concerns.
On October 2, 2026, shares of Nexalin dropped 24.1% despite a new distribution deal, with no clear catalyst identified. Integra LifeSciences fell 21.2% after lowering its 2026 revenue outlook due to flooding disruptions. Western Digital and Seagate T...

Stablecoin Development and Armada Acquisition shares surge on key corporate moves and merger approval
On October 2, 2026, Stablecoin Development Corp. shares jumped 104.4%, trading above their 50-day moving average without a clear catalyst. Armada Acquisition Corp. II rose 68.2% following shareholder approval of its merger with Evernorth, expected to...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.